Novel aspects of HDL level and function in a clinical setting

Abstract

“HDL cholesterol and ApoAI measurements are major biomarkers of coronary risk and HDL is a crucial therapeutic target. Furthermore, it is becoming clear that assessment of functional aspects of HDL, independently of concentration measurements, is fundamentalto improve risk assessment.”

Keywords:

• Atherosclerosis biomarkers
• Coronary artery disease
• Lipoproteins
• Prevention
• Reverse cholesterol transport
• Treatment